PALO ALTO, Calif., April 9, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced a new version of its Velocity™
Rapidsphere runs on the Velocity software platform, which aggregates unstructured treatment and imaging data from diverse systems to show a comprehensive view of a patient's diagnostic imaging and treatment history. Rapidsphere is an integrated image-guided dosimetry system for calculating the absorbed dose using post-treatment emission tomography imaging from Y90 SIRT. Varian will be hosting a webinar on April 13 at 3pm EDT to discuss more details about Rapidsphere. To register to view the webinar, visit www.varian.com/rapidsphere/webinar.
"At Varian, we are focused on providing clinicians with powerful and comprehensive solutions that enable them to provide personalized cancer therapy for patients," said Kolleen Kennedy, president of Varian's Oncology Systems business. "Patient-specific 3D imaging and dosimetry for targeted cancer therapy delivery is important for predicting the tumor's response to therapy. The Rapidsphere module is a significant advancement for interventional radiologists performing Y90 SIRT."
Velocity 4.0 incorporates several new features or improved functionalities. Additional new features in Velocity 4.0 include:
For more information on Velocity and Rapidsphere, visit www.varian.com/rapidsphere.
About Varian Varian is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Press ContactMark PlungyDirector, Public Relations+1 (650) 424-5630 email@example.com
Investor Relations ContactJ. Michael BruffSenior Vice President, Investor Relations+1 (650) 424-5163 firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/varian-launches-velocity-40-cancer-imaging-software-with-selective-internal-radiation-therapy-dosimetry-analysis-300625867.html
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All